Pharmafile Logo
Pharmafocus logo
Advanced Search

HRT

Showing 6 posts of 6 posts found.

The Royal College of Obstetricians and Gynaecologists (RCOG) call for action over shortages of hormone replacement therapy (HRT)

August 27, 2019
Manufacturing and Production HRT, UK, healthcare, pharma, shortages

The Royal College of Obstetricians and Gynaecologists (RCOG) have called for action from government and pharmaceutical companies to adress ongoing …

News

HRT pills linked to increase in clots and strokes

March 10, 2015
Research and Development, Sales and Marketing Cochrane, HRT, boardman, hormone replacement therapy

HRT tablets do not offer heart benefits and slightly increase the risk of strokes and blood clots in some women. …

News
Pills image

Hormone replacement therapy elevates ovarian cancer risk

February 13, 2015
Research and Development, Sales and Marketing Cancer, HRT, Lancet, Oxford, oncology, ovarian

According to a new study women who undergo hormone replacement therapy nearly double their risk of developing ovarian cancer.  Findings …

News

Evidence HRT could reduce bowel cancer risk

February 2, 2009
Research and Development, Sales and Marketing HRT

A new study has found more evidence that hormone replacement therapy (HRT) may reduce a woman's risk of bowel cancer. …

News

Latest news from Datamonitor

November 10, 2008
Research and Development, Sales and Marketing HRT

Is there an alternative to HRT for menopausal relief?Sales of hormone replacement therapy have declined recently due to safety concerns, …

News

HRT – Too great a risk ?

November 4, 2003
Research and Development HRT, clinical trial

The last 15 months have seen the image of HRT change from a miraculous medicine to a risky range of …

Feature
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026